FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for #Sup…
[ad_1]
FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for #Suprachoroidal Use for the Treatment of Macular Edema Associated with #Uveitis, the first product approved for injection into the suprachoroidal space. #eye #retina
https://t.co/R2wcsmOZP4
[ad_2]
Source by Thomas Ciulla, MD, MBA